|
Canada-0-FreightForwarding ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- Drug resistant tuberculosis: Implications for transmission, diagnosis . . .
Drug resistant TB can arise either through direct transmission of genetically resistant bacteria (transmitted resistance, Figure 2 ) or intra-patient evolution of resistance (acquired resistance, Figure 2 ) Consequently, strategies to eliminate TB need to address health systems strengthening in a manner that limits community wide TB transmission
- A comparative study of antibiotic resistance patterns in Mycobacterium . . .
Moreover, the early and precise identification of drug-resistant strains can help prevent the spread of resistant strains of TB, supporting more targeted and effective public health interventions
- Tackling Drug-Resistant Tuberculosis: New Challenges from the Old . . .
Antimicrobial resistance (AMR) in TB is a multi-factorial, complex problem of microbes evolving to escape antibiotics, the gradual decline in antibiotic development, and different economic and social conditions In this review, we summarize recent advances in our understanding of how Mycobacterium tuberculosis evolves drug resistance
- Clinical Overview of Drug-Resistant Tuberculosis Disease
Drug-resistant tuberculosis (TB) disease is caused by TB bacteria that are resistant to at least one of the most effective TB medicines Health care providers should consult a TB medical expert if drug-resistant TB disease is presumed or confirmed
- Tuberculosis: Multidrug-resistant (MDR-TB) or rifampicin-resistant TB . . .
The key factors that define treatment regimen choice include the patient's drug-resistance profile, prior exposure to TB medicines and patient history, the drug-resistance profile of close contacts, the patient’s age, the extent of pulmonary TB disease, and the localization of extrapulmonary TB lesions
- Advancing against drug-resistant tuberculosis: an extensive review . . .
Drug-resistant tuberculosis (DR-TB) represents a pressing global health issue, leading to heightened morbidity and mortality Despite extensive research efforts, the escalation of DR-TB cases underscores the urgent need for enhanced prevention, diagnosis, and treatment strategies This review delves deep into the molecular and genetic origins of different types of DR-TB, highlighting recent
- Tuberculosis treatment failure associated with evolution of antibiotic . . .
Tuberculosis caused by Mycobacterium tuberculosis is a persistent, sometimes lifelong infection that needs long courses of multiple antibiotics to treat Not surprisingly, antibiotic resistance is rife In a large sample of whole-genome data from clinical isolates, Liu et al repeatedly observed an elongated phenotype showing rapid regrowth after typical regimens of antibiotic treatment
- Advances in the mechanisms of drug resistance of Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), has developed different mechanism of action against antimicrobial drug therapies, posing a significant threat to effective treatment against Mtb This review article provides an overview of the recent advancements in the mechanism of drug resistance in Mtb and highlights how drugs target specific cellular processes
- PATTERNS OF DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: A STUDY AT . . .
The primary outcome focused on patterns of drug-resistance in MTB, while the secondary outcome aimed to determine the proportion of MDR-TB RR-TB among culture-positive patients RESULTS: The study revealed that 42 (37 83%) of cases presented drug-resistance, with MDR-TB accounting for 22 97% of the total 111 cases
- Within-host population dynamics of extensively drug-resistant
The microevolution of drug-resistant MTB within patients on long-term ineffective treatment is complex Subpopulations with different resistance-conferring mutations can compete with each other and with newly emerged subpopulations Often, one subpopulation eventually dominates and achieves long-term stability This work deepens the understanding of MTB microevolution in XDR-TB patients
|
|